Next Article in Journal
Relationship between Neutrophil-to-Lymphocyte Ratio and Inflammatory Markers in Sickle Cell Anaemia Patients with Proteinuria
Previous Article in Journal
A Soxhlet Extract of Gongronema latifolium Retains Moderate Blood Glucose Lowering Effect and Produces Structural Recovery in the Pancreas of STZ-Induced Diabetic Rats
Article

First Evidence for the Disease-Stage, Cell-Type, and Virus Specificity of microRNAs during Human Immunodeficiency Virus Type-1 Infection

1
Westmead Millennium Institute & Westmead Hospital, University of Sydney, Westmead, Sydney, NSW 2145, Australia
2
Research and Development, Australian Red Cross Blood Service, 17 O’Riordan Street, Alexandria, Sydney, NSW 2015, Australia
3
ICPMR, Department of Virology, Westmead Hospital, Westmead, Sydney, NSW 2145, Australia
*
Author to whom correspondence should be addressed.
Academic Editor: Kenth Gustafsson
Med. Sci. 2016, 4(2), 10; https://doi.org/10.3390/medsci4020010
Received: 25 February 2016 / Revised: 29 March 2016 / Accepted: 15 April 2016 / Published: 13 May 2016
The potential involvement of host microRNAs (miRNAs) in HIV infection is well documented, and evidence suggests that HIV modulates and also dysregulates host miRNAs involved in maintaining the host innate immune system. Moreover, the dysregulation of host miRNAs by HIV also effectively interferes directly with the host gene expression. In this study, we have simultaneously evaluated the expression of host miRNAs in both CD4+ and CD8+ T-cells derived from HIV-positive (HIV+) individuals (viremic and aviremic individuals while receiving highly active antiretroviral therapy (HAART), therapy-naïve long-term non-progressors (LTNP), and HIV-negative (HIV–) healthy controls. miRNAs were run on Affymetrix V2 chips, and the differential expression between HIV+ and HIV− samples, along with intergroup comparisons, was derived using PARTEK software, using an FDR of 5% and an adjusted p-value < 0.05. The miR-199a-5p was found to be HIV-specific and expressed in all HIV+ groups as opposed to HIV– controls. Moreover, these are the first studies to reveal clearly the highly discriminatory miRNAs at the level of the disease state, cell type, and HIV-specific miRNAs. View Full-Text
Keywords: CD4+ T-cells; CD8+ T-cells; micro-RNA; human immunodeficiency virus; acquired immunodeficiency syndrome; non-progression; gene expression CD4+ T-cells; CD8+ T-cells; micro-RNA; human immunodeficiency virus; acquired immunodeficiency syndrome; non-progression; gene expression
Show Figures

Figure 1

MDPI and ACS Style

Fowler, L.; Conceicao, V.; Perera, S.S.; Gupta, P.; Chew, C.B.; Dyer, W.B.; Saksena, N.K. First Evidence for the Disease-Stage, Cell-Type, and Virus Specificity of microRNAs during Human Immunodeficiency Virus Type-1 Infection. Med. Sci. 2016, 4, 10. https://doi.org/10.3390/medsci4020010

AMA Style

Fowler L, Conceicao V, Perera SS, Gupta P, Chew CB, Dyer WB, Saksena NK. First Evidence for the Disease-Stage, Cell-Type, and Virus Specificity of microRNAs during Human Immunodeficiency Virus Type-1 Infection. Medical Sciences. 2016; 4(2):10. https://doi.org/10.3390/medsci4020010

Chicago/Turabian Style

Fowler, Lauren, Viviane Conceicao, Suneth S. Perera, Priyanka Gupta, Choo B. Chew, Wayne B. Dyer, and Nitin K. Saksena 2016. "First Evidence for the Disease-Stage, Cell-Type, and Virus Specificity of microRNAs during Human Immunodeficiency Virus Type-1 Infection" Medical Sciences 4, no. 2: 10. https://doi.org/10.3390/medsci4020010

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop